RANI

Rani Therapeutics Holdings Inc

Price

$0.73

return (12m)

55.91%

p/e

-5.00

p/bv

3.14

DIVIDEND YIELD

0.00%

RANI price

Rani Therapeutics Holdings Inc

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RANI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-14.02%

3 months

12.67%

1 year

55.91%

2 years

-77.01%

5 years

-96.27%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals RANI

Valuation

P/E

-5.00

Sector 7.77

Industry 7.77

P/BV

3.14

Sector 1.72

Industry 1.72

P/Revenue (PSR)

30.89

Sector 1.69

Industry 1.69

EV/EBITDA

-11.78

Sector -5,068.50

Industry -5,068.50

EV/EBIT

-11.56

Sector -17,869.22

Industry -17,869.22

P/EBITDA

-4.78

Sector -12.84

Industry -12.84

P/EBIT

-4.67

Sector -10.90

Industry -10.90

P/Total Assets

2.48

Sector 0.81

Industry 0.81

P/Net Current Assets

3.45

Sector -1.83

Industry -1.83

P/Working Capital

3.28

Sector -19.82

Industry -19.82

EPS

-0.16

Sector 0.71

Industry 0.71

BVPS

0.26

Sector 9.79

Industry 9.79

Efficiency

Gross Margin

100.00%

Sector 35.82%

Industry 35.82%

EBITDA Margin

-483.67%

Sector -189.31%

Industry -189.31%

EBIT Margin

-100.00%

Sector 4.44%

Industry 4.44%

Net Profit Margins

-100.00%

Sector 2.53%

Industry 2.53%

Asset Turnover

0.03

Sector 0.11

Industry 0.11

Profitability

ROE

-62.81%

Sector 2.52%

Industry 2.52%

ROA

-49.54%

Sector -0.67%

Industry -0.67%

ROIC

-294.08%

Sector -120.09%

Industry -120.09%

Dividends

Dividend yield

0.00%

Sector 0.53%

Industry 0.53%

Payout

Sector 9.99%

Industry 9.99%

Debt

Current Ratio

5.31

Sector 1.47

Industry 1.47

Net Debt / EBITDA

6.46

Sector -19.88

Industry -19.88

Net Debt / EBIT

6.35

Sector -160,401,241.42

Industry -160,401,241.42

Net Debt / Equity

-1.11

Sector -0.78

Industry -0.78

Gross Debt / Equity

0.00

Sector -0.52

Industry -0.52

Equity/Assets

0.79

Sector 0.43

Industry 0.43

Liabilities/Assets

0.21

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

12.41%

Sector -

Industry -

5Y Earnings CAGR

57.18%

Sector -

Industry -

Fundamentals RANI

DRAG THE FRAME TO SEE MORE DATA

RANI - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Rani Therapeutics Holdings Inc

Rani Therapeutics Holdings Inc

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

2021

Time since IPO - 5 years

69

Employees

Rani Therapeutics Holdings Inc (United States) is listed on the Nasdaq and has a market capitalization of $150.67 million, with shareholders equity totaling $47.99 million.

The company employs approximately 69 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Rani Therapeutics Holdings Inc reported $4.88 million in revenue, generating net income of $-30.14 million.

Key financial metrics include a P/E ratio of -5.00, a price-to-book (P/B) ratio of 3.14, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RANI.

Market cap

$150.67 million

Net worth

$47.99 million

$47,985,000.00

Assets

$60.84 million

$60,843,000.00

Total Shares Outstanding

187.17 million

187,168,000

Average Daily Trading Volume

$603.86 Thousand

$603,863.32

Sector

Others

Industry

Others

RANI

RANI revenue and profits

Financial Results RANI

DRAG THE FRAME TO SEE MORE DATA

RANI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$379.23 8,55% (12M)

P/E

24.07

2.40%

ROE

13.51%

P/BV

3.25

SHEL - Shell PLC ADR

$102.57 47,58% (12M)

P/E

10.82

3.01%

ROE

14.29%

P/BV

1.55

STLA - Stellantis NV

$4.43 --56,49% (12M)

P/E

-0.51

0.00%

ROE

-35.93%

P/BV

0.18

COR - Cencora Inc.

$330.14 4,94% (12M)

P/E

23.65

0.75%

ROE

81.03%

P/BV

19.16

ALIZY - Allianz SE ADR

$47.34 --19,01% (12M)

P/E

12.88

2.91%

ROE

17.89%

P/BV

2.30

TTE - TotalEnergies SE ADR

$88.71 64,04% (12M)

P/E

6.98

4.69%

ROE

21.42%

P/BV

1.50

NSRGY - Nestle SA ADR

$92.64 3,14% (12M)

P/E

10.97

4.38%

ROE

58.05%

P/BV

6.37

ELV - Elevance Health Inc

$426.67 23,81% (12M)

P/E

20.49

1.65%

ROE

9.84%

P/BV

2.02